The molecular and genetic basis of neurological tumours
- PMID: 12154354
- DOI: 10.1038/nrc866
The molecular and genetic basis of neurological tumours
Abstract
There are no effective therapies for many tumours of the nervous system. This is, in part, a consequence of their location within relatively inaccessible tissues. It is also likely, however, that the unique characteristics of the cells that give rise to these tumours create a set of conditions that facilitate tumour development. Here, we consider recent advances in molecular genetics, the development of mouse models and developmental neurobiology as they relate to tumours of neuroectodermal origin. It is likely that these advances will provide insight into underlying mechanisms and provide a rational framework for the development of effective interventions.
Similar articles
-
Genetic basis of neurological tumours.Baillieres Clin Neurol. 1994 Aug;3(2):335-52. Baillieres Clin Neurol. 1994. PMID: 7952851 Review.
-
Molecular genetics of neuroendocrine tumors.Curr Opin Oncol. 1993 Jan;5(1):85-90. Curr Opin Oncol. 1993. PMID: 8427895 Review.
-
Are cranial germ cell tumours really tumours of germ cells?Neuropathol Appl Neurobiol. 2006 Dec;32(6):569-74. doi: 10.1111/j.1365-2990.2006.00797.x. Neuropathol Appl Neurobiol. 2006. PMID: 17083471 Review.
-
Neurofibromatosis type 1 - a model for nervous system tumour formation?Nat Rev Cancer. 2005 Jul;5(7):557-64. doi: 10.1038/nrc1653. Nat Rev Cancer. 2005. PMID: 16069817 Review.
-
Mouse models of childhood cancer of the nervous system.J Clin Pathol. 2004 Jun;57(6):561-76. doi: 10.1136/jcp.2003.009910. J Clin Pathol. 2004. PMID: 15166259 Free PMC article. Review.
Cited by
-
Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway.BMC Cancer. 2012 Sep 11;12:406. doi: 10.1186/1471-2407-12-406. BMC Cancer. 2012. PMID: 22967049 Free PMC article.
-
Glutamine synthetase functions as a negative growth regulator in glioma.J Neurooncol. 2013 Aug;114(1):59-69. doi: 10.1007/s11060-013-1168-5. Epub 2013 Jun 19. J Neurooncol. 2013. PMID: 23780646
-
Reduced Graphene Oxide Modulates the FAK-Dependent Signaling Pathway in Glioblastoma Multiforme Cells In Vitro.Materials (Basel). 2022 Aug 24;15(17):5843. doi: 10.3390/ma15175843. Materials (Basel). 2022. PMID: 36079225 Free PMC article.
-
Bioinformatics analysis reveals potential candidate drugs for different subtypes of glioma.Neurol Sci. 2013 Jul;34(7):1139-43. doi: 10.1007/s10072-012-1198-3. Epub 2012 Sep 30. Neurol Sci. 2013. PMID: 23053832
-
Gliomagenesis and the use of neural stem cells in brain tumor treatment.Anticancer Agents Med Chem. 2010 Feb;10(2):121-30. doi: 10.2174/187152010790909290. Anticancer Agents Med Chem. 2010. PMID: 20184546 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases